Pharmacokinetic comparison of different flubendazole formulations in pigs: A further contribution to its development as a macrofilaricide molecule

Alvarez, 2000, Uptake of albendazole and albendazole sulphoxide by Haemonchus contortus and Fasciola hepatica in sheep, Vet. Parasitol., 94, 75, 10.1016/S0304-4017(00)00320-4 Alvarez, 2009, Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs, Vet. Parasitol., 164, 211, 10.1016/j.vetpar.2009.05.014 Awadzi, 2003, Clinical picture and outcome of serious adverse events in the treatment of onchocerciasis, Filaria J., 2, S6, 10.1186/1475-2883-2-S1-S6 Basáñez, 2008, Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis, Lancet Infect. Dis., 8, 310, 10.1016/S1473-3099(08)70099-9 Bird, 1979, Visual loss during oral diethylcarbamazine treatment for onchocerciasis, Lancet, 2, 8132 Ceballos, 2009, Flubendazole in cystic echinococcosis therapy: pharmaco-parasitological evaluation in mice, Parasitol. Int., 58, 354, 10.1016/j.parint.2009.07.006 Ceballos, 2011, Comparative performance of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma/cysts disposition and efficacy in infected mice, Antimicrob. Agents Chemother., 55, 5861, 10.1128/AAC.05105-11 Ceballos, 2012, Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution, BMC Vet. Res., 8, 71, 10.1186/1746-6148-8-71 Ceballos, 2014, Exploring the potential of flubendazole in filariasis control: evaluation of the systemic exposure for different pharmaceutical preparations, PLoS Negl. Trop. Dis., 10.1371/journal.pntd.0002838 Dalgaard, 2015, Comparison of minipig, dog, monkey and human drug metabolism and disposition, J. Pharmacol.Toxicol. Methods., 10.1016/j.vascn.2014.12.005 EMEA, 1997 Evrard, 2002, Oral bioavailability in sheep of albendazole from a suspension on and from a solution containing hydroxypropyl-β-cyclodextrin, J. Control Release, 85, 45, 10.1016/S0168-3659(02)00270-5 Garcıa, 2003, Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole, Int. J. Pharm., 250, 351, 10.1016/S0378-5173(02)00559-8 Geary, 2010, Unresolved issues in anthelmintic pharmacology for helminthiases of humans, Int. J. Parasitol., 40, 1, 10.1016/j.ijpara.2009.11.001 Gibaldi, 1982, 45 Hennessy, 1995, The effect of a short-term reduction in feed on the pharmacokinetics and efficacy of albendazole in sheep, Aust. Vet. J., 72, 29, 10.1111/j.1751-0813.1995.tb03472.x Lanusse, 1995, Comparative plasma disposition kinetics of albendazole, fenbendazole, oxfendazole and their metabolites in adult sheep, J. Vet. Pharmacol. Ther., 18, 196, 10.1111/j.1365-2885.1995.tb00578.x Lloberas, 2012, Measurement of ivermectin concentrations in target worms and host gastrointestinal tissues: influence of the route of administration on the activity against resistant Haemonchus contortus in lambs, Exp. Parasitol., 10.1016/j.exppara.2012.04.014 Loftsson, 2007, Historical Perspectives. Cyclodextrins and their pharmaceutical applications, Int. J. Pharm., 329, 1, 10.1016/j.ijpharm.2006.10.044 Mackenzie, 2011, Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs, Expert. Rev. Anti. Infect Ther., 9, 497, 10.1586/eri.11.30 Maté, 2008, Hepatic and extra-hepatic metabolic pathways involved in flubendazole biotransformation in sheep, Biochem. Pharmacol., 76, 773, 10.1016/j.bcp.2008.07.002 Moreno, 2004, Integrated pharmacological assessment of flubendazole potential for use in sheep: disposition kinetics, liver metabolism and parasite difussion ability, J. Vet. Pharmacol. Ther., 27, 299, 10.1111/j.1365-2885.2004.00616.x Muller, 2004, SolEmuls(R)-novel technology for the formulation of i.v. emulsions with poorly soluble drugs, Int. J. Pharm., 269, 293, 10.1016/j.ijpharm.2003.09.019 Rigter, 2004, Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers, Antimicrob. Agents Chemother., 48, 1051, 10.1128/AAC.48.3.1051-1054.2004 Suarez, 2011, Comparative drug systemic exposure and clinical efficacy against resistant nematodes in lambs treated with different albendazole formulations, J. Vet. Pharmacol. Ther., 34, 557, 10.1111/j.1365-2885.2011.01274.x Taylor, 2010, Lymphatic filariasis and onchocerciasis, Lancet, 376, 1175, 10.1016/S0140-6736(10)60586-7 Toutain, 2004, Bioavailability and its assessment, J. Vet. Pharmacol. Ther., 27, 455, 10.1111/j.1365-2885.2004.00604.x Urbizu, 2012, Nematodicidal activity of flubendazole and its reduced metabolite on a murine model of Trichinella spiralis infection, Chemotherapy, 58, 295, 10.1159/000342924 WHO Programmes Wu, 2010, Absorption and tissue tolerance of ricobendazole in the presence of hydroxypropyl-β-cyclodextrin following subcutaneous injection in sheep, Int. J. Pharm., 397, 96, 10.1016/j.ijpharm.2010.07.002 Zahner, 1993, Experimental chemotherapy of filariasis: comparative evaluation of the efficacy of filaricidal compounds in Mastomys coucha infected with Litomosoides carinii, Acanthocheilonema viteae, Brugia malayi and B. pahangi, Acta Trop., 52, 221, 10.1016/0001-706X(93)90010-9